Hutch News

Hutch News

Stories tagged 'Matthias Stephan'

Dissolving implant could bring immunotherapy to solid tumors

A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study

April 24, 2017 | By Sabrina Richards / Fred Hutch News Service

A dissolving scaffold developed by Dr. Matthias Stephan delivers engineered anti-tumor immune cells to crowded masses of tumor cells and recruits the native immune system to mount a second-wave attack on the cancer.

View story >


Tiny tech reprograms immune cells to fight cancer

Nanoparticles turn immune cells into leukemia-fighting powerhouses while they’re still inside the body

April 17, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Matthias Stephan has designed nanoparticles that have the potential to make cellular immunotherapy quicker, cheaper, easier to administer and more widely available, by carrying anti-cancer genes to immune cells still inside the body.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 21, 2016

Good News: Ceballos honored for public health research; ACS research awards to three Hutch scientists; ASH grant to physician-researcher Halpern; Paulovich facilitates Moonshot panel

View story >


How research and industry partnerships can advance cancer care

Fred Hutch, Merck co-host inaugural ‘Oncology Summit’ to capture non-profit and for-profit outlooks on cancer care

Sept. 27, 2016 | By Rachel Tompa / Fred Hutch News Service

Inaugural 'Oncology Summit,' co-hosted by Fred Hutch and Merck, allowed investors, key players in life sciences to collaborate and share scientific stories.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

July 14, 2016

Dr. Matthias Stephan awarded for immunotherapy work; Dr. Melinda Miernacki gets grant; Dr. Jesse Bloom honored by American Society for Virology

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

April 21, 2016

Women’s Health Initiative receives AACR Team Science Award; Andrew Hsieh awarded AACR NextGen Grant for Transformative Cancer Research; Designing an off-the-shelf nanoparticle-based immunotherapy; Fred Hutch’s Vaccine and Infectious Disease Division contributes to early study of promising Ebola vaccine

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.